Search

Insulet Corp

Open

BrancheGesundheitswesen

167.09 1.33

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

164.31

Max

172.83

Schlüsselkennzahlen

By Trading Economics

Einkommen

-11M

91M

Verkäufe

-22M

762M

KGV

Branchendurchschnitt

38.3

62.58

EPS

1.42

Gewinnspanne

11.96

Angestellte

5,400

EBITDA

-23M

154M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+34.17% upside

Dividenden

By Acuity

Nächstes Ergebnis

5. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-278M

12B

Vorheriger Eröffnungskurs

165.76

Vorheriger Schlusskurs

167.09

Nachrichtenstimmung

By Acuity

63%

37%

295 / 340 Ranking in Healthcare

Insulet Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

27. Juli 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24. Juli 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22. Juli 2026, 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20. Juli 2026, 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Peer-Vergleich

Kursveränderung

Insulet Corp Prognose

Kursziel

By TipRanks

34.17% Vorteil

12-Monats-Prognose

Durchschnitt 221.38 USD  34.17%

Hoch 294 USD

Tief 172 USD

Basierend auf 22 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Insulet Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

22 ratings

18

Buy

3

Halten

1

Sell

Stimmung

By Acuity

295 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat